CB vs EDIT
Chubb Ltd (CB) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
CB currently screens at market cap $114.26B and trailing P/E 13.7. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the CB and EDIT stock pages for the full models.
Not investment advice.